Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Boston Scientific | 46 | 0 | 10 | 0 | €69.00 | €73.05 | 5.865% |
| Vertex Pharmaceuticals Inc. | 44 | 2 | 8 | 0 | €388.75 | €404.41 | 4.027% |
| Stryker Corp. | 23 | 0 | 8 | 0 | €307.70 | €335.03 | 8.882% |
| Intra-Cellular Therapies Inc. | 24 | 0 | 7 | 0 | €62.00 | €79.55 | 28.313% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €129.90 | €140.34 | 8.037% |
| HCA Holdings Inc. | 22 | 0 | 6 | 0 | €295.30 | €300.28 | 1.685% |
| Amgen Inc. | 25 | 0 | 6 | 0 | €290.75 | €297.31 | 2.257% |
| Biogen Inc. | 46 | 1 | 6 | 1 | €205.00 | €294.01 | 43.420% |
| Merit Medical Systems | 17 | 0 | 6 | 0 | €72.50 | €86.90 | 19.858% |
| Hologic Inc. | 17 | 0 | 5 | 0 | €71.00 | €84.52 | 19.043% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €899.00 | €957.22 | 6.476% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.83 | €28.06 | 77.242% |
| Eli Lilly Corp. | 50 | 0 | 5 | 0 | €718.70 | €766.92 | 6.709% |
| Zoetis Inc. A | 23 | 1 | 5 | 0 | €155.58 | €200.06 | 28.588% |
| Thermo Fisher Scientific Inc. | 26 | 0 | 5 | 0 | €535.10 | €566.65 | 5.895% |
| UnitedHealth Group Inc. | 33 | 1 | 4 | 0 | €469.75 | €543.72 | 15.747% |